Data / Form D filings / Xeno Biosciences Inc.
Xeno Biosciences Inc.: Form D filings
Xeno Biosciences Inc., a biotechnology company in Cambridge, MA, filed 4 Form D notices with the SEC between 2018 and 2023. The latest, on January 5, 2023, reports $1.5 million sold of a $1.5 million offering to 64 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1770 Massachusetts Avenue, Suite 224, Cambridge, MA, 02140
- Phone
- (833) 807-3142
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1748206
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | New notice | $1,500,000 | $1,500,000 | 64 | Dec 22, 2022 | sec.gov | |
| Aug 3, 2021 | New notice | $9,926,538 | $9,426,538 | $500,000 | 133 | Jul 22, 2021 | sec.gov |
| Feb 8, 2019 | New notice | $1,600,000 | $720,000 | $880,000 | 21 | Feb 1, 2019 | sec.gov |
| Aug 3, 2018 | New notice | $450,000 | $450,000 | 20 | Jul 5, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David Beno | Executive Officer, Director | |
| Jeffrey Arnold | Director | |
| Michael Koeris | Director | |
| Tom Hughes | Director | |
| Stan Rose | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jan 2, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Xeno Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.